| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 44.059 | 241.706 | 294.450 | 332.953 | 280.883 | 381.576 | 395.201 | 339.770 | 382.325 |
| Total Income - EUR | - | 44.059 | 241.706 | 294.450 | 343.068 | 297.483 | 394.451 | 445.091 | 339.770 | 382.325 |
| Total Expenses - EUR | - | 570 | 19.261 | 43.861 | 62.915 | 63.444 | 75.744 | 91.761 | 44.893 | 44.558 |
| Gross Profit/Loss - EUR | - | 43.489 | 222.445 | 250.589 | 280.153 | 234.039 | 318.707 | 353.330 | 294.877 | 337.766 |
| Net Profit/Loss - EUR | - | 42.167 | 220.028 | 247.644 | 277.074 | 231.793 | 315.991 | 349.858 | 292.348 | 326.526 |
| Employees | - | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Topgyn Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 66.683 | 70.181 | 40.431 | 109.340 | 75.739 | 21.158 | 12.084 | 5.615 |
| Current Assets | - | 44.763 | 161.390 | 189.097 | 249.699 | 125.234 | 243.879 | 339.743 | 283.964 | 409.396 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 14.780 | 55.317 | 18.092 | 22.832 | 5.323 | 21.966 | 282.071 | 137.269 | 246.931 |
| Cash | - | 29.983 | 106.073 | 171.005 | 226.867 | 119.911 | 221.913 | 57.673 | 146.695 | 162.465 |
| Shareholders Funds | - | 42.212 | 220.081 | 247.890 | 277.191 | 231.873 | 316.111 | 349.907 | 292.397 | 326.574 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.551 | 7.992 | 11.387 | 13.289 | 2.701 | 3.701 | 11.020 | 3.651 | 88.697 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Topgyn Medica Srl